Pharmadrug Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Robert Steen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO
Robert Steen
1.2yrs
Tenure
Mr. Robert J. Steen is Chief Executive Officer of Pharmadrug Inc. from September 2023 and was its Chairman since September 2023 until February 2024 and is its Director since February 2024. He has helped fo...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.2yrs | no data | no data | |
| Chairman of Advisory Board | 4.4yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 3.3yrs | CA$206.30 | no data | |
| Independent Director | 7.9yrs | CA$27.46 | 0.040% € 433.9 | |
| Member of Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 2.9yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Director | less than a year | no data | no data |
3.3yrs
Average Tenure
66.5yo
Average Age
Experienced Board: G11's board of directors are considered experienced (3.3 years average tenure).